Search

Your search keyword '"Lilly Research Laboratories"' showing total 8 results
Start Over Descriptor "Lilly Research Laboratories" Publisher plus media solutions
8 results on '"Lilly Research Laboratories"'

1. Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Workers -- Health aspects, Health care industry -- Health aspects, Medical personnel -- Health aspects, Pharmaceutical industry -- Health aspects, Hospitals, Health care industry, General interest, News, opinion and commentary
Abstract

INDIANAPOLIS: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE:LLY) will offer drive-through testing for SARS-CoV-2, the virus that causes COVID-19, to Indianapolis area [...]

Published
2020

2. Lilly, Indiana State Department of Health Partner to Accelerate COVID-19 Testing Using Lilly Research Laboratories

Subjects
United States. Department of State, United States. Food and Drug Administration, Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry, Scientists, Media executives, Chairpersons, General interest, News, opinion and commentary
Abstract

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE:LLY) announced today its scientists are partnering with the Indiana State Department of Health (ISDH), [...]

Published
2020

3. Lilly Announces New Leadership and Strategy in Oncology Research and Development

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Industrial research -- United States, Pharmaceutical industry, Research and development, General interest, News, opinion and commentary
Abstract

Dublin: Eli Lilly has issued the following press release: Eli Lilly and Company (NYSE: LLY) today announced new leadership and strategic direction in oncology R&D, combining the Lilly Research Laboratories [...]

Published
2019

4. IBRI announces research team for its Diabetes Center

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Diabetes research, Diabetes therapy, Pharmaceutical industry, Type 1 diabetes, Therapeutics, Biotechnology, General interest, News, opinion and commentary
Abstract

Indiana: Indiana Biosciences Research Institute has issued the following press release: The Indiana Biosciences Research Institute (IBRI) today announced new investigators for the IBRI Diabetes Center (IDC). At its first [...]

Published
2019

5. Profile of Mike Clayman, MD Chief Executive Officer & Co-Founder of Flexion Therapeutics

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Chief executive officers, Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

Burlington: Following is the Profile of Mike Clayman, MD Chief Executive Officer & Co-Founder of Flexion Therapeutics: Dr. Clayman is a co-founder of Flexion Therapeutics and has served as our [...]

Published
2016

6. Profile of Steven M. Paul, M.D. Director of Alnylam Pharmaceuticals, Inc

Subjects
United States. National Institute of Mental Health, Alnylam Pharmaceuticals Inc., Eli Lilly and Co., Lilly Research Laboratories, Biotechnology industries, Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

Cambridge: Following is the Profile of Steven M. Paul, M.D. Director of Alnylam Pharmaceuticals, Inc.: Chief Executive Officer, President and board member of Voyager Therapeutics, Inc.; Venture Partner at Third [...]

Published
2016

7. Profile of Director Jan M. Lundberg, Ph.D. Executive Vice President, Science and Technology, and President, Lilly Research Laboratories of Eli Lilly and Company

Subjects
AstraZeneca PLC, Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

Indiana: Following is the Profile of Director Jan M. Lundberg, Ph.D. Executive Vice President, Science and Technology, and President, Lilly Research Laboratories of Eli Lilly and Company:Jan Lundberg is executive [...]

Published
2016

8. Profile of Director Jan M. Lundberg, Ph.D. Executive Vice President, Science and Technology, and President, Lilly Research Laboratories of Eli Lilly and Company

Subjects
AstraZeneca PLC, Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

Indiana: Following is the Profile of Director Jan M. Lundberg, Ph.D. Executive Vice President, Science and Technology, and President, Lilly Research Laboratories of Eli Lilly and Company:Jan Lundberg is executive [...]

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results